- Home
- CELZ vs TCRT Comparison
CELZ vs TCRT Comparison
Compare CELZ & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- TCRT
- Stock Information
- Founded
- CELZ 1998
- TCRT 1998
- Country
- CELZ United States
- TCRT United States
- Employees
- CELZ N/A
- TCRT N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- TCRT Health Care
- Exchange
- CELZ Nasdaq
- TCRT Nasdaq
- Market Cap
- CELZ 4.7M
- TCRT 3.8M
- IPO Year
- CELZ N/A
- TCRT N/A
- Fundamental
- Price
- CELZ $2.55
- TCRT $2.39
- Analyst Decision
- CELZ
- TCRT
- Analyst Count
- CELZ 0
- TCRT 0
- Target Price
- CELZ N/A
- TCRT N/A
- AVG Volume (30 Days)
- CELZ 62.2K
- TCRT 15.9K
- Earning Date
- CELZ 11-08-2024
- TCRT 11-14-2024
- Dividend Yield
- CELZ N/A
- TCRT N/A
- EPS Growth
- CELZ N/A
- TCRT N/A
- EPS
- CELZ N/A
- TCRT N/A
- Revenue
- CELZ $11,000.00
- TCRT $7,000.00
- Revenue This Year
- CELZ N/A
- TCRT N/A
- Revenue Next Year
- CELZ N/A
- TCRT N/A
- P/E Ratio
- CELZ N/A
- TCRT N/A
- Revenue Growth
- CELZ N/A
- TCRT N/A
- 52 Week Low
- CELZ $2.41
- TCRT $1.95
- 52 Week High
- CELZ $10.28
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- CELZ 36.30
- TCRT 54.94
- Support Level
- CELZ $2.41
- TCRT $2.07
- Resistance Level
- CELZ $2.67
- TCRT $2.38
- Average True Range (ATR)
- CELZ 0.29
- TCRT 0.21
- MACD
- CELZ -0.05
- TCRT 0.04
- Stochastic Oscillator
- CELZ 11.21
- TCRT 48.35
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.